PDF) FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG) | I. Varthalitis
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
a Number of delayed cycles (\2 cycles, C2 cycles), b number of delayed... | Download Scientific Diagram
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis BOUKOVINAS | Bioclinic Thessaloniki, Thessaloníki | Oncology Unit
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Endogenous and Exogenous Risk Factors of Patients Surveyed for... | Download Table
Unadjusted (Observed) and Case Mix-Adjusted Prevalence Rates for... | Download Table
PDF) Case-Mix Adjustment Approach to Benchmarking Prevalence Rates of Nosocomial Infection in Hospitals in Cyprus and Greece
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
I. Varthalitis's research works | Hellenic Cooperative Oncology Group, Athens (HeCOG) and other places
PDF) A multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer
Univariate and Multivariate Analysis of Risk Factors for Mortality... | Download Table
REMARK diagram for biomarker studies. | Download Scientific Diagram
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept